Myriad Payables Turnover from 2010 to 2024
| MYGN Stock | USD 16.28 0.11 0.68% |
Payables Turnover | First Reported 2010-12-31 | Previous Quarter 9.15503876 | Current Value 9.61 | Quarterly Volatility 2.46335197 |
Check Myriad Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Myriad Genetics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 65 M, Total Revenue of 414.1 M or Gross Profit of 327.5 M, as well as many indicators such as Price To Sales Ratio of 2.0, Dividend Yield of 0.22 or PTB Ratio of 1.92. Myriad financial statements analysis is a perfect complement when working with Myriad Genetics Valuation or Volatility modules.
Myriad | Payables Turnover |
Latest Myriad Genetics' Payables Turnover Growth Pattern
Below is the plot of the Payables Turnover of Myriad Genetics over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Myriad Genetics' Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Myriad Genetics' overall financial position and show how it may be relating to other accounts over time.
| Payables Turnover | 10 Years Trend |
|
Payables Turnover |
| Timeline |
Myriad Payables Turnover Regression Statistics
| Arithmetic Mean | 6.47 | |
| Coefficient Of Variation | 38.08 | |
| Mean Deviation | 1.60 | |
| Median | 6.82 | |
| Standard Deviation | 2.46 | |
| Sample Variance | 6.07 | |
| Range | 10.3373 | |
| R-Value | 0.72 | |
| Mean Square Error | 3.18 | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 0.39 | |
| Total Sum of Squares | 84.95 |
Myriad Payables Turnover History
About Myriad Genetics Financial Statements
Myriad Genetics investors utilize fundamental indicators, such as Payables Turnover, to predict how Myriad Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Payables Turnover | 9.16 | 9.61 |
Pair Trading with Myriad Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myriad Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Myriad Stock
| 0.75 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.86 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.96 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Myriad Stock
| 0.91 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.87 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.66 | PMVP | Pmv Pharmaceuticals | PairCorr |
| 0.58 | PHVS | Pharvaris BV | PairCorr |
| 0.47 | PLRX | Pliant Therapeutics | PairCorr |
The ability to find closely correlated positions to Myriad Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myriad Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myriad Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myriad Genetics to buy it.
The correlation of Myriad Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myriad Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myriad Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myriad Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Myriad Genetics Correlation against competitors. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Revenue Per Share 9.205 | Quarterly Revenue Growth 0.112 | Return On Assets (0.05) | Return On Equity (0.16) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.